Who owns Capricor Therapeutics Inc?
- Ticker: CAPR
- CUSIP Number: 14070b309
Tip: Access positions for across all investors
Analyze quarterly positions in Capricor Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Capricor Therapeutics stock
Who bought or sold Capricor Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.4M | $9.3M | 17% | Mar 2024 |
|
| Susquehanna International | 421k | $2.9M | 43% | Mar 2024 |
|
| BlackRock | 382k | $2.6M | 6% | Mar 2024 |
|
| Geode Capital Management | 329k | $2.2M | 22% | Mar 2024 |
|
| Millennium Management | 293k | $2.0M | 1293% | Mar 2024 |
|
| Goldman Sachs Group | 213k | $1.4M | 1299% | Mar 2024 |
|
| Advisor Group Holdings | 158k | $1.1M | 36% | Mar 2024 |
|
| Northern Trust | 120k | $817k | 15% | Mar 2024 |
|
| Morgan Stanley | 112k | $758k | 161% | Mar 2024 |
|
| Arrowstreet Capital, Limited Partnership | 102k | $689k | 100% | Mar 2024 |
|
| Jane Street | 93k | $629k | 131% | Mar 2024 |
|
| Jpmorgan Chase & Co | 91k | $619k | 100% | Mar 2024 |
|
| Hrt Financial | 83k | $560k | 100% | Mar 2024 |
|
| Citigroup | 78k | $532k | 229% | Mar 2024 |
|
| Citadel Advisors | 75k | $507k | 92% | Mar 2024 |
|
| Man Group | 73k | $495k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 71k | $480k | -17% | Mar 2024 |
|
| Qube Research & Technologies | 69k | $471k | 1133% | Mar 2024 |
|
| Cubist Systematic Strategies | 54k | $369k | 100% | Mar 2024 |
|
| Jump Financial | 53k | $258k | 100% | Dec 2023 |
|
| Walleye Trading Advisors | 48k | $324k | 100% | Mar 2024 |
|
| LPL Financial | 46k | $315k | -43% | Mar 2024 |
|
| Wells Fargo & Company | 33k | $221k | 13697% | Mar 2024 |
|
| Commonwealth Equity Services | 31k | $210k | 0% | Mar 2024 |
|
| HighTower Advisors | 30k | $199k | 100% | Mar 2024 |
|
| Occudo Quantitative Strategies | 26k | $177k | 100% | Mar 2024 |
|
| Simplex Trading | 25k | $171k | -41% | Mar 2024 |
|
| ExodusPoint Capital Management | 25k | $167k | 100% | Mar 2024 |
|
| Two Sigma Investments | 24k | $163k | 22% | Mar 2024 |
|
| Point72 Asia | 24k | $161k | 100% | Mar 2024 |
|
| Bank of America Corporation | 22k | $149k | -7% | Mar 2024 |
|
| Main Street Financial Solutions | 20k | $136k | 100% | Mar 2024 |
|
| Y-Intercept | 20k | $133k | 100% | Mar 2024 |
|
| Brevan Howard Capital Management | 20k | $132k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 14k | $92k | 0% | Mar 2024 |
|
| Balyasny Asset Management | 13k | $88k | 100% | Mar 2024 |
|
| Woodline Partners | 13k | $85k | 100% | Mar 2024 |
|
| LLBH Private Wealth Management | 11k | $74k | 0% | Mar 2024 |
|
| Leucadia National Corporation | 11k | $72k | 100% | Mar 2024 |
|
| Us Bancorp | 7.5k | $51k | 0% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 5.8k | $40k | 100% | Mar 2024 |
|
| Tower Research Capital | 4.8k | $33k | -46% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 1.9k | $13k | 100% | Mar 2024 |
|
| Householder Group Estate & Retirement Specialist | 1.5k | $10k | 0% | Mar 2024 |
|
| UBS Group | 1.5k | $10k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 1.4k | $10k | -86% | Mar 2024 |
|
| Harel Insurance Investments & Financial Services | 689.00 | $5.0k | 0% | Mar 2024 |
|
| YHB Investment Advisors | 150.00 | $1.0k | 100% | Mar 2024 |
|
| FMR | 1.00 | $7.000000 | 100% | Mar 2024 |
|
Who sold out of Capricor Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Group One Trading | Sep 2023 | 36k | $123k |
| GSA Capital Partners | Dec 2023 | 33k | $161k |
| Dimensional Fund Advisors | Dec 2023 | 15k | $73k |
| McGlone Suttner Wealth Management | Dec 2023 | 423.00 | $2.1k |
| New Millennium Group | Dec 2023 | 59.00 | $288.999700 |